These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5606515)

  • 1. [Drug induced jaundice with unconjugated bilirubin].
    Emond M
    Union Med Can; 1967 Jul; 96(7):847-8. PubMed ID: 5606515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of novobiocin on liver function. Clinical study].
    Emond M; Erlinger S; Berthelot P; Benhamou JP; Fauvert R
    Can Med Assoc J; 1966 Apr; 94(17):900-4. PubMed ID: 4952370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of unconjugated hyperbilirubinemia.
    Powell LW
    Semin Hematol; 1972 Jan; 9(1):91-105. PubMed ID: 4550945
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-induced icterus due to unconjugated bilirubin].
    Berthelot P; Benhamou JP; Fauvert R
    Actual Hepatogastroenterol (Paris); 1966; 2(1):488-92. PubMed ID: 5963842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Jaundice due to novobiocin: report of 3 cases].
    Alvariz FG
    Rev Bras Med; 1969 Apr; 26(4):221-2. PubMed ID: 5800213
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of drugs on bilirubin metabolism in the treatment of jaundice].
    Shakun NP; Oleinik AN
    Vrach Delo; 1973 Nov; 11():44-7. PubMed ID: 4786932
    [No Abstract]   [Full Text] [Related]  

  • 7. [JAUNDICE WITH INDIRECT BILIRUBIN DETERMINATION IN THE COURSE OF A PROLONGED NOVOBIOCIN TREATMENT].
    CHAPTAL J; JEAN R; BONNET H
    Ann Pediatr (Paris); 1964 Feb; 11():113-8. PubMed ID: 14136396
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the liver transport of bile pigments in certain forms of jaundice under the influence of novobiocin and luminal].
    Goranov I; Avramova K
    Probl Khig; 1975; 1():165-70. PubMed ID: 1235996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observations on the enzyme activity of experimental icterus due to novobiocin].
    Cenci GP; Cucchi G; De Arcangelis A; Rendace P; Alessandrini A
    Epatologia; 1966; 12(5):841-8. PubMed ID: 5986012
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative aspects of osmotic opening of the blood-brain barrier in experimental hyperbilirubinemia].
    Domínguez Ortega F; Martín Zarza M; Ormazábal Ramos JC; Rodríguez Luis JC; Doménech Martínez E
    An Esp Pediatr; 1993 Dec; 39(6):493-7. PubMed ID: 8166402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonconjugated hyperbilirubinemia of drug origin and hepatic glucuro-conjugation].
    Berthelot P; Préaux AM; Dhumeaux D
    Biol Gastroenterol (Paris); 1971; 3():Suppl 3:255-6. PubMed ID: 5126106
    [No Abstract]   [Full Text] [Related]  

  • 12. [Jaundice caused by novobiocin].
    Persico L
    Policlinico Prat; 1966 Nov; 73(48):1607-14. PubMed ID: 5998996
    [No Abstract]   [Full Text] [Related]  

  • 13. [Jaundice caused by novobiocin].
    Lupescu C; Voiciloiu T
    Med Interna (Bucur); 1966 Dec; 18(12):1519-21. PubMed ID: 5980272
    [No Abstract]   [Full Text] [Related]  

  • 14. Jaundice in the adult patient.
    Roche SP; Kobos R
    Am Fam Physician; 2004 Jan; 69(2):299-304. PubMed ID: 14765767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced jaundice].
    Araki Y
    Nihon Rinsho; 1972 Sep; 30(9):1865-70. PubMed ID: 4405518
    [No Abstract]   [Full Text] [Related]  

  • 16. Jaundice in a patient treated with Anakinra in a context of Covid-19.
    Tarhini H; Husain M; Poey N; Lariven S; Lescure FX; Yazdanpanah Y; Gervais A
    Infect Dis Now; 2021 Mar; 51(2):217-218. PubMed ID: 33010355
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histological study (light microscopy) of recurrent jaundice due to familial defect of bilirubin excretion without liver involvement].
    Orellana Alcalde JM; Lemus J; Pablo Dominguez J
    Rev Med Chil; 1968 Jun; 96(6):419-21. PubMed ID: 5720751
    [No Abstract]   [Full Text] [Related]  

  • 18. NMDA channel antagonist MK-801 does not protect against bilirubin neurotoxicity.
    Shapiro SM; Sombati S; Geiger A; Rice AC
    Neonatology; 2007; 92(4):248-57. PubMed ID: 17556843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced hyperbilirubinemia and the clinical influencing factors.
    Ah YM; Kim YM; Kim MJ; Choi YH; Park KH; Son IJ; Kim SG
    Drug Metab Rev; 2008; 40(4):511-37. PubMed ID: 18821100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver injury associated with the beta-interferons for MS.
    Wallack EM; Callon R
    Neurology; 2004 Sep; 63(6):1142-3; author reply 1142-3. PubMed ID: 15452330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.